Citation Impact

1 by Nobel laureates 64 standout
Sub-graph 1 of 22

Citing Papers

Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Lung cancer statistics, 2023
2024 Standout
5 intermediate papers

Works of Alan Mitchell being referenced

The IASLC Lung Cancer Staging Project
2015

Author Peers

Author Hematology Oncology Molecular Biology PRM Last Decade Papers Cites
Alan Mitchell 369 341 262 349 19 821
Rafael Lopes Oliveira 2 11 141
Szetsen Lee 1 96 1 38 758
N. F. Svaiter 98 936
Deborah Ash 123 2 3 19 319
T. D. Donnelly 4 7 27 1.7k

All Works

Loading papers...

Rankless by CCL
2026